Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | EVP, Operations | July 27, 2012 | July 31, 2012 |
| Stevanato Group S.p.A.STVN · Entity 3826 | Director | March 18, 2026 | March 18, 2026 |
| XBiotech Inc.XBIT · Entity 7044 | Director | June 19, 2017 | June 23, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date July 27, 2012 · Filed July 31, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,608 |
Reported balance
After 2012-07-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2012-07-27 · Exercise / conversion · Acquired 42,109 · Balance 115,608 |
| Common StockSEC Table I · non-derivative | Direct | 157,510 |
Reported balance
After 2012-07-27 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2012-07-27 · Exercise / conversion · Acquired 41,902 · Balance 157,510 |
| Common StockSEC Table I · non-derivative | Direct | 187,510 |
Reported balance
After 2012-07-27 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2012-07-27 · Exercise / conversion · Acquired 30,000 · Balance 187,510 |
| Common StockSEC Table I · non-derivative | Direct | 271,510 |
Reported balance
After 2012-07-27 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2012-07-27 · Exercise / conversion · Acquired 84,000 · Balance 271,510 |
| Common StockSEC Table I · non-derivative | Direct | 334,510 |
Reported balance
After 2012-07-27 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2012-07-27 · Exercise / conversion · Acquired 63,000 · Balance 334,510 |
| Common StockSEC Table I · non-derivative | Direct | 376,510 |
Reported balance
After 2012-07-27 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2012-07-27 · Exercise / conversion · Acquired 42,000 · Balance 376,510 |
| Common StockSEC Table I · non-derivative | Direct | 73,499 |
Reported balance
After 2012-07-27 transaction · row 8
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 8 · 2012-07-27 · Gift · Disposed 303,011 · Balance 73,499 F1: These shares are being transferred to the reporting person's Family Trust. F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3: These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 363,639 |
Reported balance
After 2012-07-27 transaction · row 7
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 7 · 2012-07-27 · Gift · Acquired 303,011 · Balance 363,639 F1: These shares are being transferred to the reporting person's Family Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 60,628 |
Reported balance
After 2012-07-27 transaction · row 9
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 9 · 2012-07-27 · Sale · Disposed 303,011 · Balance 60,628 F4: The price reported is an average price. The prices ranged from $81.56 to $82.48 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 48,491 |
Reported balance
After 2012-07-30 transaction · row 10
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 10 · 2012-07-30 · Sale · Disposed 12,137 · Balance 48,491 F5: The price reported is an average price. The prices ranged from $84.32 to $84.37 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.88 · Expires 2013-04-03 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2012-07-27 · Exercise / conversion · Disposed 42,109 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.55 · Expires 2014-04-26 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2012-07-27 · Exercise / conversion · Disposed 41,902 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.79 · Expires 2014-10-29 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2012-07-27 · Exercise / conversion · Disposed 30,000 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.13 · Expires 2015-04-29 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2012-07-27 · Exercise / conversion · Disposed 84,000 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.44 · Expires 2016-04-28 | Direct | 21,000 |
Reported balance
After 2012-07-27 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2012-07-27 · Exercise / conversion · Disposed 63,000 · Balance 21,000 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.43 · Expires 2020-04-26 | Direct | 42,000 |
Reported balance
After 2012-07-27 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2012-07-27 · Exercise / conversion · Disposed 42,000 · Balance 42,000 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are being transferred to the reporting person's Family Trust.
F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3: These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F4: The price reported is an average price. The prices ranged from $81.56 to $82.48 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
F5: The price reported is an average price. The prices ranged from $84.32 to $84.37 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
Stevanato Group S.p.A.
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | IndirectSecurities owned by you as trustee By Self as Co-Trustee for Self and Spouse | 119,700 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 119,700 |
XBiotech Inc.
Report date June 19, 2017 · Filed June 23, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.24 · Expires 2027-06-19 | Direct | 50,000 |
Reported balance
After 2017-06-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-19 · Exercise / conversion · Acquired 50,000 · Balance 50,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 19, 2017 Filed Jun 23, 2017 18:21 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Option · Derivative | 50,000 | $4.24 Strike: $4.24 | $212,000.00 |
DisclosureSEC source: 0001209191-17-041611 · doc4.xml · derivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-06-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 19:05 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Option · Derivative | 50,000 | $13.26 Strike: $13.26 | $663,000.00 |
DisclosureSEC source: 0001209191-16-141752 · doc4.xml · derivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: On September 14, 2016 (the Grant Date) Fabrizio Bonanni was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market, with an expiry of ten years from the Grant Date. Half of the Options vest on December 20, 2016 and another half of the Options vest on June 20, 2017. Read SEC document |
| July 30, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 12,137 | $84.33 | $1,023,561.76 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · nonDerivative · entry 10 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 48,491 F5 · price: The price reported is an average price. The prices ranged from $84.32 to $84.37 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 42,000 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · derivative · entry 16 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 63,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · derivative · entry 15 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 63,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 84,000 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · derivative · entry 14 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,000 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $56.79 | $0.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · derivative · entry 13 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2014-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 41,902 | $0.00 Strike: $62.55 | $0.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · derivative · entry 12 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,902 shares Expires 2014-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 42,109 | $0.00 Strike: $71.88 | $0.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · derivative · entry 11 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,109 shares Expires 2013-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 303,011 | $82.14 | $24,888,717.52 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · nonDerivative · entry 9 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 60,628 F4 · price: The price reported is an average price. The prices ranged from $81.56 to $82.48 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 303,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · nonDerivative · entry 8 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,499 F1 · kind: These shares are being transferred to the reporting person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 303,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · nonDerivative · entry 7 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 363,639 F1 · kind: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 42,000 | $58.43 | $2,454,060.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · nonDerivative · entry 6 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 63,000 | $50.44 | $3,177,720.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · nonDerivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 84,000 | $42.13 | $3,538,920.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 30,000 | $56.79 | $1,703,700.00 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 41,902 | $62.55 | $2,620,970.10 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 42,109 | $71.88 | $3,026,794.92 |
DisclosureSEC source: 0001127602-12-023276 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2012 Filed May 4, 2012 22:52 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 4,929 | $70.85 | $349,204.37 |
DisclosureSEC source: 0001127602-12-015978 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 60,628 F1 · price: The price reported is an average price. The prices ranged from $70.84 to $70.86 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| May 03, 2012 Filed May 4, 2012 22:52 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,643 | $70.89 | $116,474.73 |
DisclosureSEC source: 0001127602-12-015978 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 65,557 Read SEC document |
| April 29, 2012 Filed May 2, 2012 00:40 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015245 · form4.xml · nonDerivative · entry 7 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 67,200 F2 · kind: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| April 29, 2012 Filed May 2, 2012 00:40 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015245 · form4.xml · nonDerivative · entry 6 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,454 F2 · kind: These shares are being transferred to the reporting person's Family Trust. F3 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2012 Filed May 2, 2012 00:40 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,357 | $71.64 | $97,215.48 |
DisclosureSEC source: 0001127602-12-015245 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,097 Read SEC document |
| April 28, 2012 Filed May 2, 2012 00:40 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015245 · form4.xml · nonDerivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 65,557 F2 · kind: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| April 28, 2012 Filed May 2, 2012 00:40 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015245 · form4.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,454 F2 · kind: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| April 28, 2012 Filed May 2, 2012 00:40 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,357 | $71.64 | $97,215.48 |
DisclosureSEC source: 0001127602-12-015245 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,097 Read SEC document |
| April 27, 2012 Filed May 2, 2012 00:40 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 8,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015245 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,454 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Read SEC document |
| April 26, 2012 Filed Apr 30, 2012 21:06 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-014946 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 63,914 F1 · kind: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| April 26, 2012 Filed Apr 30, 2012 21:06 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-014946 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,800 F1 · kind: These shares are being transferred to the reporting person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; and 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 26, 2012 Filed Apr 30, 2012 21:06 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,357 | $70.19 | $95,247.83 |
DisclosureSEC source: 0001127602-12-014946 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,443 Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 21:39 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 5,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-011435 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 62,271 F1 · kind: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 21:39 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 5,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-011435 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,800 F1 · kind: These shares are being transferred to the reporting person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; 40,000 RSUs which vest fully on 12/31/2013; and 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 21:39 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 5,098 | $68.26 | $347,989.48 |
DisclosureSEC source: 0001127602-12-011435 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,622 Read SEC document |
| March 14, 2012 Filed Mar 15, 2012 23:38 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 10,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-010809 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,720 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; 40,000 RSUs which vest fully on 12/31/2013; and 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| February 01, 2012 Filed Feb 3, 2012 01:04 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 7,745 | $69.63 | $539,320.75 |
DisclosureSEC source: 0001127602-12-003806 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 56,449 F1 · price: The price reported is an average price. The prices ranged from $69.63 to $69.65 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001127602-12-003246 · form4.xml · derivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2012-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:44 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 50,000 | $68.44 | $3,421,920.00 |
DisclosureSEC source: 0001127602-12-003246 · form4.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 64,194 F3 · price: The price reported is an average price. The prices ranged from $68.35 to $68.55 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:44 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-003246 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 114,194 F1 · shares: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:44 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-003246 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,800 F1 · shares: These shares are being transferred to the reporting person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; 40,000 RSUs which vest fully on 12/31/2013; and 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:44 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 50,000 | $58.61 | $2,930,500.00 |
DisclosureSEC source: 0001127602-12-003246 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2011 Filed Nov 10, 2011 01:57 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $58.12 | $581,233.00 |
DisclosureSEC source: 0001127602-11-029177 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 64,194 F1 · price: The price reported is an average price. The prices ranged from $58.12 to $58.15 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:09 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-014435 · form4.xml · nonDerivative · entry 6 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 74,194 F1 · shares: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:09 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-014435 · form4.xml · nonDerivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,800 F1 · shares: These shares are being transferred to the reporting person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; 40,000 RSUs which vest fully on 12/31/2013; and 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:09 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,357 | $57.14 | $77,538.98 |
DisclosureSEC source: 0001127602-11-014435 · form4.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,443 Read SEC document |
| April 28, 2011 Filed May 2, 2011 23:09 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-014435 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 72,551 F1 · shares: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| April 28, 2011 Filed May 2, 2011 23:09 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-014435 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,800 F1 · shares: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| April 28, 2011 Filed May 2, 2011 23:09 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,357 | $56.82 | $77,104.74 |
DisclosureSEC source: 0001127602-11-014435 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,443 Read SEC document |
| April 26, 2011 Filed Apr 28, 2011 01:05 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-013880 · form4.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 70,908 F2 · shares: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| April 26, 2011 Filed Apr 28, 2011 01:05 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-013880 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,800 F2 · shares: These shares are being transferred to the reporting person's Family Trust. F3 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/28/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; 40,000 RSUs which vest fully on 12/31/2013; and 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 26, 2011 Filed Apr 28, 2011 01:05 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,357 | $54.69 | $74,214.33 |
DisclosureSEC source: 0001127602-11-013880 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,443 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.